Biomica's discovery pipeline is enabled by a unique Computational Predictive Biology (CPB) platform combining biological ‘Big-Data’.
The company has invested significant efforts in developing specialized computational tools for high-resolution taxonomy and functional profiling of the human microbiome.
Cutting edge Artificial Intelligence analysis technologies, providing next-generation solutions accounting for complex host-microbiome interrelations.
Biomica aims to identify and target microbes, metabolites and other microbiome-related components
that are key in the pathogenesis of human diseases impacted by the microbiome, using both biological and small-molecule approaches.
Biomica’s discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform.
Employing a holistic approach, PRISM combines a profound understanding of the microbiome and its functions and their intricate relations with the human host.
Our platform relies on a multi-layered analysis of omic and clinical/ phenotypic data using an extensive nexus of modules in four key areas.
enabling high-resolution taxonomy analysis of the microbial community down to the strain level.
functional-level microbial community analysis profiling microbial genes, pathways and metabolites
profiling of patients' genomic information (genetics and expression patterns)
relevant phenotypic and physiological information manifested in patients
Identification of unique microbiome-based therapeutic entities through multilayered analysis & integration of high resolution big-data
Microbiome therapeutics pipeline
Immuno-oncology (with ICI)
Combination Therapy for Cancer
MDRO (Multi Drug resistant organisms)
Targeting Antibiotic Resistant Bacteria
GI related disorders
GI Inflammatory & Functional Disorders
- Biological approach
- Small-molecule approach
Biomica is a subsidiary of Evogene Ltd.
(NASDAQ, TASE: EVGN)
Evogene is a pioneer in the field of applied computational predictive biology developing novel products for life science markets. Biomica leverages Evogene's capabilities, vast experience and established expertise of predictive biology.